![]() |
| BioMarin Announces Program for ERT for Treatment of MPS IVA |
|
RSS FEED
|
BioMarin Pharmaceutical Inc. today announced its program for its third enzyme replacement therapy for the treatment of mucopolysaccharidosis IVA , or Morquio A Syndrome. Read more... |
||||||||||||
|
|
|||||||||||||
| BioMarin Announces Program for ERT for Treatment of MPS IVA |
|
||
|
Site Map
|
Sitemap |

